RÉSUMÉ
It was already shown that microdoses of lithium carbonate (Li2CO3) promoted memory stabilization in humans and mice. Prolonged treatment also reduced neuronal loss and increased the density of the neurotrophin BDNF in transgenic mice for Alzheimer's disease. The aim of this study was to evaluate whether lithium ions affect inflammatory profiles and neuronal integrity in an animal model of accelerated senescence (SAMP-8). Organotypic hippocampal cultures obtained from 11 to 12-month-old SAMP-8 mice were treated with 2 µM, 20 µM and 200 µM Li2CO3. 2 µM Li2CO3 promoted a significant reduction in propidium iodide uptake in the CA2 area of hippocampus, whereas 20 µM promoted neuroprotection in the CA3 and GrDG areas. 200 µM caused an increase in cellular death, showing toxicity. Measured with quantitative PCR, IL-1α, IL-6 and MIP-1B/CCL-4 gene expression was significantly reduced with 20 µM Li2CO3, whereas IL-10 gene expression was significantly increased with the same concentration. In addition, 2 µM and 20 µM Li2CO3 were also effective in reducing the activation of NFkB and inflammatory cytokines densities, as evaluated by ELISA. It is concluded that very low doses of Li2CO3 can play an important role in neuroprotection as it can reduce neuronal loss and neuroinflammation in older individuals.
Sujet(s)
Mort cellulaire/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Lithium/pharmacologie , Neuroprotecteurs/pharmacologie , Composés phénylés du mercure/pharmacologie , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/métabolisme , Animaux , Modèles animaux de maladie humaine , Hippocampe/métabolisme , Souris transgéniques , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolismeRÉSUMÉ
In the present study, the antifungal effects of phenylmercuric nitrate and benzalkonium chloride versus those of natamycin and ketoconazole were assessed against 216 filamentous fungi isolates from cases of fungal keratitis. They included 112 Fusarium isolates, 94 Aspergillus isolates, and 10 Alternaria alternata isolates. The strains were tested by broth dilution antifungal susceptibility testing of filamentous fungi approved by the Clinical and Laboratory Standards Institute M38-A document. The results showed that the MIC(50) values of phenylmercuric nitrate were 0.0156, 0.0156, and 0.0313 µg/mL for Fusarium spp., Aspergillus spp., and A. alternata, respectively. The MIC(90) values of phenylmercuric nitrate were 0.0313, 0.0313, and 0.0313 µg/mL for Fusarium spp., Aspergillus spp., and A. alternata, respectively. The MIC(50) values of benzalkonium chloride were 16, 32, and 8 µg/mL for Fusarium spp., Aspergillus spp., and A. alternata, respectively. The MIC(90) values of benzalkonium chloride were 32, 32, and 16 µg/mL for Fusarium spp., Aspergillus spp., and A. alternata, respectively. The study indicates that phenylmercuric nitrate has considerable antifungal activity and its effect is significantly superior to those of benzalkonium chloride, natamycin, and ketoconazole against ocular pathogenic filamentous fungi in vitro, deserving further investigation for treating fungal keratitis as a main drug.
Sujet(s)
Alternaria/effets des médicaments et des substances chimiques , Aspergillus/effets des médicaments et des substances chimiques , Composés de benzalkonium/pharmacologie , Fusarium/effets des médicaments et des substances chimiques , Solutions ophtalmiques/composition chimique , Composés phénylés du mercure/pharmacologie , Conservateurs pharmaceutiques/pharmacologie , Alternaria/isolement et purification , Antifongiques/pharmacologie , Aspergillus/isolement et purification , Fusarium/isolement et purification , Humains , Kératite/microbiologie , Tests de sensibilité microbienneRÉSUMÉ
Permeability coefficients of rat and rabbit erythrocyte membranes for a series of amides, as well as for erythrocytes treated with p-chloromercuribenzenesulfonic acid monosodium salt (pCMBS) have been determined at 25 and 37 degrees C. Directly proportional dependence of the pCMBS treated erythrocyte permeability for investigated substances and their partition coefficients between the hydrophobic phase and water as well as the values of activation energy of this process indicate that penetration of small hydrophilic molecules is realized by passive diffusion through the lipid bilayer. The results obtained indicate that penetration of small hydrophilic molecules of formamide through lipids is determined by the existence of a free space between hydrocarbon chains that arises from kink formation. The differences in permeability between rat and rabbit erythrocyte membranes could arise in particular as a result of the differences in lipid composition.
Sujet(s)
Amides/métabolisme , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Membrane érythrocytaire/métabolisme , Érythrocytes/cytologie , Érythrocytes/métabolisme , Animaux , Érythrocytes/ultrastructure , Lipides membranaires/métabolisme , Composés phénylés du mercure/pharmacologie , Lapins , Rats , TempératureRÉSUMÉ
The purpose of the studies was to choose additives for eye drops containing cefazolin and the assessment of the influence of used additives and the storage temperature on the physicochemical properties and the stability of the eye drops. The drops were 1% sterile solutions of cefazolin in citrate buffer of pH 6.15-6.20. The drops were preserved with 0.002% thiomersal or 0.001% phenylmercuric borate mixed with 0.4% beta-phenylethyl alcohol. Viscosity of the eye drops was increased using polyvinyl alcohol (PVAL). The pharmaceutical compatibility test of selected additives with cefazolin showed the pharmaceutical interaction of 1% solution of cefazolin with higher than 0.003% concentration of thiomersal, 0.005% benzalkonium chloride and 0.01% chlorhexidine diacetate. The drops, protected from light, were stored at the temperature of 4 degrees C and 20 degrees C. As the criteria of the qualitative assessment of freshly prepared drops and during their storage, the following properties were considered: organoleptic analysis, sterility, pH, osmotic pressure, density, viscosity, antimicrobial activity of cefazolin and preservation efficiency of thiomersal and phenylmercuric borate in the eye drops. The studies showed that the storage temperature did not influence the physicochemical properties of the drops or the antimicrobial activity of cefazolin in the drops, which was not influenced by the used additives either. After 30 days of storage at both temperatures, cefazolin in the eye drops retained 100% of its initial activity. Phenylmercuric borate, whose antimicrobial activity in the eye drops was compatible with the preservation assay cited in the Polish Pharmacopoeia (PPh V), can be used to preserve the drops containing cefazolin.
Sujet(s)
Antibactériens/pharmacologie , Céfazoline/pharmacologie , Solutions ophtalmiques/pharmacologie , Composés phénylés du mercure/pharmacologie , Conservateurs pharmaceutiques/pharmacologie , Bactéries/effets des médicaments et des substances chimiques , Chimie pharmaceutique , Basse température , Stabilité de médicament , Stockage de médicament , Champignons/effets des médicaments et des substances chimiques , Humains , Tests de sensibilité microbienne , Solutions ophtalmiques/composition chimiqueRÉSUMÉ
The role of ATP-stimulated P2X1 receptors in human platelets is still unclear. They may act alone or in synergy with other pathways, such as P2Y1 or P2Y12 receptors, to accelerate and enhance calcium mobilisation, shape change and aggregation. To date very few pharmacological means of selectively inhibiting platelet P2X1 receptors have been described, although recent work has shown that suramin is a useful lead compound for the development of high-affinity P2X1 antagonists. We therefore investigated the effects of a series of bivalent and tetravalent suramin analogues on alphabeta meATP (P2X1 receptors)-induced or ADP (P2Y1 receptors)-induced intracellular calcium increases and shape change, as well as on ADP-induced aggregation (P2Y1 & P2Y12 receptors) in human platelets. Changes in intracellular calcium were measured using standard fluorescence techniques, while shape change and aggregation were determined by turbidimetry. The novel tetravalent compound NF864 (8,8',8'',8'''-(carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino)))tetrakis-naphthalene-1,3,5-trisulfonic acid-dodecasodium salt) proved to be the most potent platelet P2X1 antagonist reported to date, blocking alphabeta meATP-induced Ca2+ increases and shape change in a concentration-dependent manner, with a pA2 of 8.17 and 8.49, respectively. The ability to inhibit the platelet P2X1 receptor displayed the following order : NF864 > NF449 > or = NF110 > NF023 = MK-HU1 = suramin. A different antagonistic profile was observed for ADP-induced Ca2+ increases, shape change and aggregation; however, overall four compounds showed sufficient ability to selectively inhibit P2X1 responses, with the order NF110 > NF449 > or = NF864 > or = MK-HU1. Therefore, these compounds should prove useful tools for investigating the functional significance of platelet P2X1 receptors in thrombosis and haemostasis, NF864 being the most promising compound.
Sujet(s)
Plaquettes/effets des médicaments et des substances chimiques , Antagonistes des récepteurs purinergiques P2 , Suramine/analogues et dérivés , Suramine/pharmacologie , ADP/analogues et dérivés , ADP/pharmacologie , Adénosine triphosphate/analogues et dérivés , Adénosine triphosphate/pharmacologie , Apyrase/antagonistes et inhibiteurs , Plaquettes/métabolisme , Calcium/métabolisme , Forme de la cellule/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Humains , Méthode des moindres carrés , Modèles linéaires , Composés phénylés du mercure/pharmacologie , Antiagrégants plaquettaires/pharmacologie , Récepteurs purinergiques P2/métabolisme , Récepteurs purinergiques P2X , Récepteurs purinergiques P2Y1 , Thionucléotides/pharmacologieRÉSUMÉ
Bovine pulmonary artery smooth muscle tissue possesses matrix metalloproteinase-2 (72 kDa gelatinase: MMP-2; E.C. 3.4.24.24) as revealed by immunoblot studies of its plasma membrane suspension with polyclonal MMP-2 antibody. In this report, we described the purification and partial characterization of MMP-2 in the plasma membrane fraction of the smooth muscle. MMP-2 has been purified from plasma membrane fraction of bovine pulmonary artery smooth muscle to homogeneity using a combination of purification steps. Heparin sepharose purified preparation of 72 kDa progelatinase is composed of two distinct population of zymogens: a 72 kDa progelatinase tightly complexed with TIMP-2 (an ambient tissue inhibitor of metalloprotease in the smooth muscle plasma membrane), and a native 72 kDa progelatinase free of any detectable TIMP-2. The homogeneity of the native 72 kDa progelatinase form is demonstrated by SDS-PAGE under non-reducing condition, non-denaturing native gel electrophoresis. The purified TIMP-2 free proenzyme electrophoresed as a single band of 72 kDa which could be activated by APMA with the formation of 62 and 45 kDa active species. The proenzyme is activated poorly by trypsin but not by plasmin. The purified 72 kDa progelatinase is stable at aqueous solution and does not spontaneously autoactivate. The purified 72 kDa gelatinase exhibited properties that are typical of MMP-2 obtained from other sources. These are: (i) its activity is dependent on the divalent cation, Ca+2, and is inhibited by EDTA, EGTA and 1:1 0-phenanthroline; (ii) it was inhibited by a, macroglobulin but not by the inhibitors of serine, cysteine, thiol, aspartic proteinases and calpains; (iii) it was found to be inhibited by TIMP-2, the specific inhibitor of MMP-2; (iv) like MMP-2, obtained from other sources, its major substrates were found to be collagens (type IV and V) and gelatins (type I, IV and V). Additionally, the purified MMP-2 degrades Dnp-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH (dinitrophenyl labelled peptide), a well known synthetic substrate for the MMP-2.
Sujet(s)
Membrane cellulaire/enzymologie , Proenzymes , Matrix metalloproteinase 2 , Muscles lisses vasculaires/enzymologie , Artère pulmonaire/enzymologie , Animaux , Bovins , Collagène de type IV/composition chimique , Collagène de type V/composition chimique , Activation enzymatique/effets des médicaments et des substances chimiques , Proenzymes/composition chimique , Proenzymes/isolement et purification , Gélatine/composition chimique , Matrix metalloproteinase 2/composition chimique , Matrix metalloproteinase 2/isolement et purification , Composés phénylés du mercure/pharmacologie , Artère pulmonaire/cytologie , Spécificité du substratRÉSUMÉ
The IscS protein is a pyridoxal phosphate-containing cysteine desulfurase involved in iron-sulfur cluster biogenesis. In prokaryotes, IscS is also involved in various metabolic functions, including thio-modification of tRNA. By contrast, the eukaryotic ortholog of IscS (Nfs1) has thus far been shown to be functional only in mitochondrial iron-sulfur cluster biogenesis. We demonstrate here that yeast Nfs1p is also required for the post-transcriptional thio-modification of both mitochondrial (mt) and cytoplasmic (cy) tRNAs in vivo. Depletion of Nfs1p resulted in an immediate impairment of the 2-thio-modification of 5-carboxymethylaminomethyl-2-thiouridine at the wobble positions of mt-tRNA(UUU)(Lys) and mt-tRNA(UUG)(Gln). In addition, we observed a severe reduction in the 2-thio-modification of 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)U) of cy-tRNA(UUU)(Lys2) and cy-tRNA(UUC)(Glu3), although the effect was somewhat delayed compared with that seen in mt-tRNAs. Mass spectrometry analysis revealed an increase in 5-methoxycarbonylmethyluridine concomitant with a decrease in mcm(5)s(2)U in cy-tRNAs that were prepared from Nfs1p-depleted cells. These results suggest that Nfs1p is involved in the 2-thio-modification of both 5-carboxymethylaminomethyl-2-thiouridine in mt-tRNAs and mcm(5)s(2)U in cy-tRNAs.
Sujet(s)
Cytoplasme/métabolisme , Mitochondries/métabolisme , ARN de transfert/métabolisme , Protéines de Saccharomyces cerevisiae/physiologie , 4-Thiouridine/analogues et dérivés , Technique de Northern , Ferrosulfoprotéines/composition chimique , Spectrométrie de masse , Protéines mitochondriales , Modèles chimiques , Composés phénylés du mercure/pharmacologie , Maturation post-transcriptionnelle des ARN , Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/métabolisme , Sulfurtransferases , 4-Thiouridine/composition chimique , Facteurs temps , Uridine/composition chimiqueRÉSUMÉ
Matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs) are emerging as important modulators of brain physiopathology. Dramatic changes in the expression of MMPs and TIMPs occur during excitotoxic/neuroinflammatory processes. However, only the measurement of net protease activity is relevant physiologically, and the functional consequences of MMP/TIMP ratio modifications in the brain remain elusive. In order to assess MMP activity and effects in brain tissue, we combined in vivo and organotypic culture models of kainate (KA)-induced excitotoxicity to provoke selective neuronal death and neuroinflammation in the hippocampus. Using in situ zymography, we show that KA-induced excitotoxic seizures in rats increase net MMP activity in hippocampal neurons 8 h after seizures, before their death, and that this increase is neuronal activity-dependent. Three days after KA, proteolytic activity increases in blood vessels and reactive glial cells of vulnerable areas, in relation with neuroinflammation. At 7 and 15 days, proteolysis remains high in blood vessels whereas it is reduced in glia. In organotypic hippocampal cultures, which lack blood cell-mediated inflammation and extrinsic connections, a broad-spectrum inhibitor of MMPs (MMPI), but also a selective MMP-9 inhibitor, protect hippocampal neurons against KA-induced excitotoxicity. Moreover, recombinant MMP-9, but not MMP-2, induces selective pyramidal cell death in these cultures and KA-induced neuronal activity exacerbates the neuronal death promoting effects of MMP-9. These data strongly implicate MMPs, and MMP-9 in particular, in both excitotoxic neuronal damage and subsequent neuroinflammatory processes, and suggest that selective MMPIs could be therapeutically relevant in related neurological disorders.
Sujet(s)
Antigènes CD , Antigènes néoplasiques , Antigènes de surface , Protéines aviaires , Protéines du sang , Encéphalite/enzymologie , Agonistes des acides aminés excitateurs/toxicité , Acide kaïnique/toxicité , Matrix metalloproteinases/métabolisme , Neurones/effets des médicaments et des substances chimiques , Crises épileptiques/métabolisme , Animaux , Antigènes CD147 , Vaisseaux sanguins/métabolisme , Numération cellulaire , Mort cellulaire/effets des médicaments et des substances chimiques , Diazépam/pharmacologie , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Interactions médicamenteuses , Modulateurs GABA/pharmacologie , Protéine gliofibrillaire acide/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/anatomopathologie , Immunohistochimie , Mâle , Matrix metalloproteinase 9/métabolisme , Glycoprotéines membranaires/métabolisme , Névroglie/effets des médicaments et des substances chimiques , Névroglie/métabolisme , Neurones/enzymologie , Techniques de culture d'organes , Phénanthrolines/pharmacologie , Composés phénylés du mercure/pharmacologie , Inhibiteurs de protéases/pharmacologie , Rats , Rat Wistar , Crises épileptiques/induit chimiquement , Crises épileptiques/enzymologie , Facteurs temps , Inhibiteur tissulaire de métalloprotéinase-1/pharmacologieRÉSUMÉ
Previous work had demonstrated that organomercurial-mediated modification of two cysteine residues in the vesicular acetylcholine transporter (VAChT) from Torpedo californica inhibits binding of vesamicol. The cysteines are protected by acetylcholine and vesamicol (Keller et al. 2000. J. Neurochem. 74:1739-1748). Modified "cysteine 1" is accessible to glutathione from the cytoplasmic surface, whereas modified "cysteine 2" is not. Different organomercurials and aqueous environments were used here to characterize diffusion pathway(s) leading to the cysteines. para-Chloromercuriphenylsulfonate modifies VAChT much more slowly than do more hydrophobic p-chloromercuribenzoate and phenylmercury chloride. Permeabilization of vesicles with cholate detergent increases the rate of modification by p-chloromercuriphenylsulfonate. Permeabilization does not affect the ability of glutathione to reverse modification by p-chloromercuriphenylsulfonate. Higher ionic strength causes about four-fold increase in the rate of modification. The results suggest that hydrophobic and electrostatic barriers inhibit modification of Torpedo VAChT by negatively charged organomercurials and glutathione cannot reach cysteine 2 from either side of the membrane.
Sujet(s)
Protéines de transport/composition chimique , Cystéine/effets des médicaments et des substances chimiques , Protéines de transport membranaire , Composés organiques du mercure/pharmacologie , Torpedo/métabolisme , Protéines du transport vésiculaire , 4-Chloromercurio-benzènesulfonate/pharmacologie , Animaux , Diffusion , Ions , Concentration osmolaire , Perméabilité , Composés phénylés du mercure/pharmacologie , Chlorure de sodium/pharmacologie , Vésicules synaptiques/métabolisme , Transporteurs vésiculaires de l'acétylcholine , Chlorure de 4-carboxyphényl-mercure/pharmacologieRÉSUMÉ
Endostatin, a 20-kDa collagen XVIII fragment, inhibits angiogenesis and tumor growth in vivo, but the mechanisms are still unclear. Matrix metalloproteases (MMPs), a family of extracellular and membrane-associated endopeptidases, collectively digest almost all extracellular matrix and basement membrane components, and thus play an important role in tumor progression. We studied the effects of recombinant human endostatin on human MMP-2, -9, -8, and -13. We found that endostatin inhibited the activation and catalytic activity of pro-MMP-9 and -13 as well as recombinant pro-MMP-2. It prevented the fragmentation of pro-MMP-2 that was associated with reduction of catalytic activity. Endostatin had no effect on MMP-8 as shown by collagenase activity assays. An in vitro migration assay and an in vivo chicken chorioallantoic membrane intravasation assay with the human tongue squamous cell carcinoma cell line HSC-3 revealed the biphasic nature of endostatin; low endostatin concentrations inhibited intravasation and migration of these cells in a dose-dependent manner, but at increased concentrations, the inhibitory effect was far less efficient. The results show that endostatin blocks the activation and activities of certain tumor-associated pro-MMPs, such as pro-MMP-2, -9, and -13, which may explain, at least in part, the antitumor effect of endostatin. Our results also suggest that endostatin inhibits tumor progression by directly affecting the tumor cells and not just acting via endothelial cells and blockage of angiogenesis.
Sujet(s)
Antinéoplasiques/pharmacologie , Collagène/pharmacologie , Activation enzymatique/effets des médicaments et des substances chimiques , Inhibiteurs de métalloprotéinases matricielles , Invasion tumorale , Fragments peptidiques/pharmacologie , Tumeurs de la langue/traitement médicamenteux , Tumeurs de la langue/anatomopathologie , Technique de Western , Collagène de type XVIII , Endostatines , Gelatinases/métabolisme , Humains , Cinétique , Matrix Metalloproteinase 13 , Composés phénylés du mercure/pharmacologie , Protéines recombinantes/pharmacologie , Cellules cancéreuses en cultureRÉSUMÉ
Thalidomide is known to induce oxidative stress, but mechanisms have not been described through which oxidative stress could contribute to thalidomide-induced terata. Oxidative stress modulates intracellular glutathione (GSH) and redox status and can perturb redox-sensitive processes, such as transcription factor activation and/or binding. Nuclear factor-kappa B (NF-kappaB), a redox-sensitive transcription factor involved in limb outgrowth, may be modulated by thalidomide-induced redox shifts. Thalidomide-resistant Sprague-Dawley rat embryos (gestation day [GD] 13) treated with thalidomide in utero showed no changes in GSH distribution in the limb but thalidomide-sensitive New Zealand White rabbit embryos (GD 12) showed selective GSH depletion in the limb bud progress zone (PZ). NF-kappaB and regulatory genes that initiate and maintain limb outgrowth and development, such as Twist and Fgf-10, are selectively expressed in the PZ. Green fluorescent protein (GFP) reporter vectors containing NF-kappaB binding promoter sites were transfected into both rat and rabbit limb bud cells (LBCs). Treatment with thalidomide caused a preferential decrease in GFP expression in rabbit LBCs but not in rat LBCs. N-acetylcysteine and alpha-N-t-phenylbutyl nitrone (PBN), a free radical trapping agent, rescued GFP expression in thalidomide-treated cultures compared with cultures that received thalidomide only. In situ hybridization showed a preferential decrease in Twist, Fgf-8, and Fgf-10 expression after thalidomide treatment (400 mg/kg per day) in rabbit embryos. Expression in rat embryos was not affected. Intravenous cotreatment with PBN and thalidomide (gavage) in rabbits restored normal patterns and localization of Twist, Fgf-8, and Fgf-10 expression. These findings show that NF-kappaB binding is diminished due to selective thalidomide-induced redox changes in the rabbit, resulting in the significant attenuation of expression of genes necessary for limb outgrowth.
Sujet(s)
Membres/embryologie , Régulation de l'expression des gènes au cours du développement , Facteur de transcription NF-kappa B/métabolisme , Oxydoréduction , Thalidomide , Animaux , Glutathion/métabolisme , Protéines à fluorescence verte , Immunohistochimie , Hybridation in situ , Protéines luminescentes/pharmacologie , Stress oxydatif , Composés phénylés du mercure/pharmacologie , Lapins , Rats , Rat Sprague-Dawley , Tératogènes , Facteurs temps , TransfectionRÉSUMÉ
The extracellular matrix (ECM) is an important regulator of mammary epithelial cell (MEC) function and is remodeled by matrix metalloproteinases (MMPs). To investigate the significance and regulation of MMP activity in normal MEC, we utilized a primary culture model in which rat MEC were grown three dimensionally within a reconstituted basement membrane (RBM) in defined serum-free medium. Zymograms of culture medium demonstrated that five major gelatinases of 97, 80, 74, 69, and 65 kDa were secreted by MEC and were distinct from gelatinases of RBM origin. Based on molecular weight, p-aminophenylmercuric acid activation, immunoblotting with MMP-specific antibodies, inhibition by EDTA, a peptide containing the prodomain sequence of MMP (TMRKPRCGNPDVAN) and two synthetic MMP inhibitors (BB-94 and CGS 27023A), these were classified as inactive and active forms of MMP-9 and MMP-2. The maximal MMP activities occurred when MEC were in a rapid proliferation and branching phase and declined after they underwent functional differentiation. Known regulators of MEC growth and differentiation were evaluated for their ability to modulate gelatinase activity in primary culture. Secretion of one or both MMPs was inhibited by EGF, TGFalpha, prolactin, and hydrocortisone and stimulated by progesterone. Furthermore, the functional significance of MMPs was demonstrated since three MMP inhibitors blocked branching morphogenesis elicited by the absence of hydrocortisone. Additionally, two synthetic MMP inhibitors not only inhibited epithelial cell growth but also inhibited normal alveolar development of the MEC. Finally, these drugs were found to enhance MMP secretion from MEC, although the activity of the secreted MMPs was inhibited as long as the drug was present.
Sujet(s)
Cellules épithéliales/cytologie , Matrice extracellulaire/métabolisme , Gelatinases/métabolisme , Acides hydroxamiques , Glandes mammaires animales/cytologie , Matrix metalloproteinases/métabolisme , Phénylalanine/analogues et dérivés , Pyrazines , Animaux , Taille de la cellule/effets des médicaments et des substances chimiques , Cellules cultivées , Milieux de culture conditionnés , Milieux de culture sans sérum , Facteur de croissance épidermique/métabolisme , Cellules épithéliales/effets des médicaments et des substances chimiques , Cellules épithéliales/enzymologie , Matrice extracellulaire/composition chimique , Femelle , Humains , Immunotransfert , Glandes mammaires animales/effets des médicaments et des substances chimiques , Glandes mammaires animales/enzymologie , Inhibiteurs de métalloprotéinases matricielles , Souris , Organoïdes/métabolisme , Peptides/pharmacologie , Phénylalanine/pharmacologie , Composés phénylés du mercure/pharmacologie , Inhibiteurs de protéases/pharmacologie , Rats , Rat Sprague-Dawley , Sulfonamides , Thiophènes/pharmacologie , Facteur de croissance transformant alpha/métabolismeSujet(s)
Bradykinine/analogues et dérivés , Guanosine monophosphate/analogues et dérivés , Guanosine monophosphate/composition chimique , Guanosine monophosphate/isolement et purification , Peptides/composition chimique , ARN/composition chimique , ARN/isolement et purification , Soufre/métabolisme , Alkylation , Bradykinine/synthèse chimique , Catalyse , Relation dose-effet des médicaments , Électrophorèse sur gel de polyacrylamide , Techniques génétiques , Guanosine monophosphate/synthèse chimique , Guanosine monophosphate/pharmacologie , Cinétique , Composés phénylés du mercure/synthèse chimique , Composés phénylés du mercure/pharmacologie , Agarose/composition chimique , Thionucléotides/synthèse chimique , Thionucléotides/pharmacologie , Transcription génétiqueRÉSUMÉ
Properties of cysteinyl residues in the vesicular acetylcholine transporter (VAChT) of synaptic vesicles isolated from Torpedo californica were probed. Cysteine-specific reagents of different size and polarity were used and the effects on [3H]vesamicol binding determined. The vesamicol dissociation constant increased 1,000-fold after reaction with p-chloromercuriphenylsulfonate or phenylmercury acetate, but only severalfold after reaction with relatively small methylmercury chloride or methylmethanethiosulfonate (MMTS). Methylmercury chloride, but not MMTS, protected binding from phenylmercury acetate. Thus, two classes of cysteines react to affect vesamicol binding. Class 1 reacts with only organomercurials, and class 2 reacts with both organomercurials and MMTS. Quantitative analysis of the competition between p-chloromercuriphenylsulfonate and VAChT ligands was possible after defining second-order reaction conditions. The results indicate that each cysteinyl class probably contains a single residue. Acetylcholine protects cysteine 1, but apparently does not protect cysteine 2. Vesamicol, which binds to a different site than acetylcholine does, apparently protects both cysteines, suggesting that it induces a conformational change. The relatively large reagent glutathione removes a substituent from cysteine 1, but not cysteine 2, suggesting that cysteine 2 is deeper in the transporter than cysteine 1 is. The complete sequence of T. californica VAChT is given, and possible identities of cysteines 1 and 2 are discussed.
Sujet(s)
Acétylcholine/métabolisme , Protéines de transport/métabolisme , Cystéine/métabolisme , Protéines de transport membranaire , Curarisants dépolarisants/métabolisme , Pipéridines/métabolisme , Protéines du transport vésiculaire , 4-Chloromercurio-benzènesulfonate/analogues et dérivés , 4-Chloromercurio-benzènesulfonate/métabolisme , Acétylcholine/pharmacologie , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Sites de fixation/effets des médicaments et des substances chimiques , Sites de fixation/physiologie , Fixation compétitive , Protéines de transport/composition chimique , Protéines de transport/génétique , Cytoplasme/composition chimique , Cytoplasme/métabolisme , Relation dose-effet des médicaments , Glutathion/pharmacologie , Méthanesulfonate de méthyle/analogues et dérivés , Méthanesulfonate de méthyle/pharmacologie , Composés méthylés du mercure/pharmacologie , Données de séquences moléculaires , Curarisants dépolarisants/pharmacologie , Composés organiques du mercure/pharmacologie , Composés phénylés du mercure/pharmacologie , Pipéridines/pharmacologie , Structure tertiaire des protéines , Torpedo , Transporteurs vésiculaires de l'acétylcholineRÉSUMÉ
Methylmercury is a highly toxic, organic derivative found in mercury-polluted wetlands and coastal sediments worldwide. Though commonly present at low concentrations in the substrate, methylmercury can biomagnify to concentrations that poison predatory animals and humans. In the interest of developing an in situ detoxification strategy, a model plant system was transformed with bacterial genes (merA for mercuric reductase and merB for organomercurial lyase) for an organic mercury detoxification pathway. Arabidopsis thaliana plants expressing both genes grow on 50-fold higher methylmercury concentrations than wild-type plants and up to 10-fold higher concentrations than plants that express merB alone. An in vivo assay demonstrated that both transgenes are required for plants to detoxify organic mercury by converting it to volatile and much less toxic elemental mercury.
Sujet(s)
Arabidopsis/génétique , Génie génétique/méthodes , Produits dangereux/métabolisme , Composés organiques du mercure/métabolisme , Végétaux génétiquement modifiés/métabolisme , Polluants atmosphériques/métabolisme , Arabidopsis/enzymologie , Dépollution biologique de l'environnement , Résistance aux substances , Écologie , Gaz , Lyases/génétique , Lyases/métabolisme , Mercure/métabolisme , Composés méthylés du mercure/métabolisme , Composés méthylés du mercure/pharmacologie , Modèles biologiques , Composés organiques du mercure/pharmacologie , Oxidoreductases/génétique , Oxidoreductases/métabolisme , Phénotype , Composés phénylés du mercure/métabolisme , Composés phénylés du mercure/pharmacologie , Polluants du sol/métabolisme , Polluants chimiques de l'eau/métabolismeRÉSUMÉ
The actions of the nitric oxide (NO) donors 1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3 methyl-1-triazine (NOC-7), S-nitrosoacetylcysteine (CySNO) and S-nitrosoglutathione (GSNO) on the purified calcium release channel (ryanodine receptor) of rabbit skeletal muscle were determined by single channel current recordings. In addition, the activation of the NO donor modulated calcium release channel by the sulfhydryl oxidizing organic mercurial compound 4-(chloromercuri)phenylsulfonic acid (4-CMPS) was investigated. NOC-7 (0.1 and 0.3 mM) and CySNO (0.4 and 0.8 mM) increased the open probability (P(o)) of the calcium release channel at activating calcium concentrations (20-100 microM Ca(2+)) by 60-100%, with no effect on the current amplitude; this activation was abolished by the specific sulfhydryl reducing agent DTT. High concentrations of CySNO (1.6-2 mM) decreased P(o). Activation by GSNO (1 mM) was observed in two thirds of the experiments, but 2 mM and 4 mM GSNO markedly reduced P(o) at activating Ca(2+) (20-100 microM). In contrast to 4-CMPS, NOC-7 or GSNO had no effect at subactivating free Ca(2+) (0.6 microM). 4-CMPS further increased the open probability of NOC-7- or CySNO-stimulated channels and reversed transiently the reduced open probability of CySNO or GSNO inhibited channels at activating free Ca(2+). High concentrations of GSNO did not prevent channel activation of 4-CMPS at subactivating free Ca(2+). The NOC-7-, CySNO- or GSNO-modified channels were completely blocked by ruthenium red. It is suggested that nitrosylation/oxidation of sulfhydryls by NO donors and oxidation of sulfhydryls by 4-CMPS affect different cysteine residues essential in the gating of the calcium release channel.
Sujet(s)
Inhibiteurs des canaux calciques/pharmacologie , Muscles squelettiques/métabolisme , Donneur d'oxyde nitrique/pharmacologie , Canal de libération du calcium du récepteur à la ryanodine/effets des médicaments et des substances chimiques , Acétylcystéine/analogues et dérivés , Acétylcystéine/pharmacologie , Animaux , Calcium/pharmacologie , Dithiothréitol/pharmacologie , Glutathion/analogues et dérivés , Glutathion/pharmacologie , Hydrazines/pharmacologie , Composés nitrosés/pharmacologie , Composés organiques du mercure/pharmacologie , Oxydoréduction , Composés phénylés du mercure/pharmacologie , Lapins , Canal de libération du calcium du récepteur à la ryanodine/isolement et purification , Canal de libération du calcium du récepteur à la ryanodine/métabolisme , S-Nitroso-glutathion , Thiols/pharmacologieRÉSUMÉ
Pseudomonas putida (UWC1), containing a genetically-engineered plasmid (pQM899), that encodes for the production of catechol 2,3-dioxygenase (C230), was used as a potential means of rapidly estimating bactericidal activity of chlorhexidine diacetate (CHA), phenol, cetylpyridinium chloride (CPC) and phenylmercuric nitrate (PMN). Enzyme C230 converts catechol to 2-hydroxymuconic semialdehyde (2-HMS), which is yellow in colour, via a meta cleavage pathway. Ideal conditions for production and measurement spectrophotometrically of 2-HMS were determined. However, the correlation between this method and viable plate counts was not sufficiently accurate to enable 2-HMS production to provide a sufficiently sensitive determination of biocidal activity. An alternative method, synchronous scanning fluorimetry, in which the decrease in catechol concentration was measured under standardized conditions, provided a good dose-response histogram for all the biocides tested. Although, in comparison with plate counts, there was an underestimation of the bactericidal effects of phenol an PMN, the results of this study suggest that this method has potential in determining the bactericidal efficacy of agents such as CHA and CPC.
Sujet(s)
Éléments transposables d'ADN , Dioxygenases , Désinfectants/pharmacologie , Oxygénases/génétique , Oxygénases/métabolisme , Pseudomonas putida/effets des médicaments et des substances chimiques , Catechol 2,3-dioxygenase , Cétylpyridinium/pharmacologie , Chlorhexidine/pharmacologie , Numération de colonies microbiennes , Fluorimétrie , Tests de sensibilité microbienne , Phénol/pharmacologie , Composés phénylés du mercure/pharmacologie , Plasmides , Pseudomonas putida/enzymologie , Pseudomonas putida/croissance et développement , Spectrophotométrie UVRÉSUMÉ
The physiological function of a new gene, hereby designated merG, located between merA and merB on the broad-spectrum mer operon of Pseudomonas strain K-62 plasmid pMR26 was investigated. The 654-bp merG gene encodes a protein with a canonical leader sequence at its N terminus. The processing of the signal peptide of this protein was dose-dependently inhibited by sodium azide, a potent inhibitor of protein export. These results suggest that the mature MerG protein (ca. 20 kDa) may be located in the periplasm. Deletion of the merG gene from the broad-spectrum mer operon of pMR26 had no effect on the inorganic mercury resistance phenotype, but rendered the bacterium more sensitive to phenylmercury than its isogenic wild-type strain. Escherichia coli cells bearing pMU29, which carries a deletion of the merG gene, took up significantly more phenylmercury than the bacteria with the intact plasmid pMRA17. When the merG gene in a compatible plasmid was transformed into the E. coli strain carrying pMU29, the high uptake of and high sensitivity to phenylmercury were almost completely restored to their original levels. These results demonstrate that the merG gene is involved in phenylmercury resistance, presumably by reducing in-cell permeability to phenylmercury.
Sujet(s)
Protéines bactériennes/génétique , Résistance microbienne aux médicaments/génétique , Lyases , Opéron , Composés phénylés du mercure/pharmacologie , Pseudomonas/génétique , Protéines bactériennes/métabolisme , Transport biologique , Clonage moléculaire , Escherichia coli/génétique , Escherichia coli/métabolisme , Délétion de gène , Cinétique , Mercure/métabolisme , Plasmides , Canaux potassiques , Pseudomonas/effets des médicaments et des substances chimiques , Protéines de fusion recombinantes/métabolisme , Cartographie de restrictionRÉSUMÉ
Membrane lactate transport was studied in skeletal muscle cells and membrane vesicles from the L6 line in relation to in vitro myogenesis. In myoblasts, lactate was transported by simple diffusion and insensitive to classical inhibitors: a positive correlation between onset of creatine kinase activity and lactate transport in differentiated myotubes was observed and could be considered to be a functional marker of cell differentiation. In myotubes, complete analysis of the velocity curves (direct coordinates, Eadie-Scatchard plots, Hill plots) gave parameters showing that lactate was carried by an allosteric or multisite system. This was confirmed by using sarcolemmal vesicles and specific inhibitors. In whole cells, alpha-cyano-4-hydroxycinnamic acid (CIN) and parachloromercuribenzylsulphonic acid (pCMBS) inhibited the maximal velocity without modifying the global cooperativity of the system. The weak effect of 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid (DIDS), which has a low affinity constant (Ki = 22.5 microM), implicated the monocarboxylate system rather than the anionic exchanger as a carrier system in muscle cells. CIN and DIDS exhibited one type of interaction with lactate carriers, and the curvilinear shape of the lactate Hill plot with or without inhibitors suggested that inhibitors were active at the same family of interaction sites and had a common range of affinities. The apparent competitive inhibition of pyruvate (Ki = 3.2 mM) did not modify the transport pathway of lactate in L6 myotubes. In conclusion, kinetic analysis of lactate transport in the presence or absence of inhibitors gave evidence for a multisite lactate carrier activity in myotubes composed of two systems at least, related to two or three isoforms of lactate carriers.